Pirfenidone Pirfact 267mg Tablets
Pirfenidone Pirfact 267mg Tablets

Pirfenidone Pirfact 267mg Tablets

MOQ : 100 Pieces

Pirfenidone Pirfact 267mg Tablets Specification

  • Dosage Form
  • Tablet
  • Indication
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Salt Composition
  • Pirfenidone 267mg
  • Feature
  • Prescription medicine for the treatment of lung fibrosis
  • Application
  • Oral antifibrotic therapy
  • Physical Color/Texture
  • Film-coated tablet
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store in a cool, dry place below 25C. Protect from light.
  • Shelf Life
  • 24 months
  • Route of Administration
  • Oral
  • Prescription Required
  • Yes
  • Packaging Size
  • 30 tablets per box
  • Precautions
  • Use with caution in patients with liver or kidney impairment
  • Country of Approval
  • Globally approved in several countries (seen in image: Canada, EU, UK, USA, Australia)
  • Strength
  • 267mg
  • Brand Name
  • Pirfact
 

Pirfenidone Pirfact 267mg Tablets Trade Information

  • Minimum Order Quantity
  • 100 Pieces
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Pieces Per Month
  • Delivery Time
  • 2-10 Days
  • Main Domestic Market
  • All India
 

Pirfenidone Pirfact 267mg Tablets About



Pirfenidone Pirfact 267mg Tablets stand as a rare and trending breakthrough in the treatment of Idiopathic Pulmonary Fibrosis (IPF). With a globally unassailable reputation-approved in Canada, the EU, UK, USA, and Australia-Pirfact offers an ineffable promise for patients exploring modern antifibrotic therapies. Each box contains 30 film-coated, odorless tablets, containing Pirfenidone 267mg. Designed for oral administration, this prescription medicine offers a towering approach to managing lung fibrosis. Use with caution in patients with liver or kidney issues. Store below 25C, protected from light.

Distinctive Features and Suitability for Use

Pirfenidone Pirfact 267mg Tablets are film-coated and virtually odorless, ensuring a comfortable oral experience. Specifically indicated for the management of idiopathic pulmonary fibrosis, these tablets are suitable for adult patients under physician guidance. Their effectiveness is underscored by global regulatory approvals and a robust safety profile. With a shelf life of 24 months, the clever packaging preserves their potency, making them reliable for both immediate and future use.


Timely Delivery and Domestic Market Support

Pirfact 267mg Tablets are dispatched promptly throughout the domestic market, ensuring reliable delivery timelines. Sample policies are available on request to accommodate medical institutions and distributors seeking trial quantities. Delivered to your location in secure packaging, these tablets cater to the needs of hospitals, pharmacies, and healthcare providers across India. Thorough tracking and customer support accompany each shipment, affirming confidence in every order placed.


FAQ's of Pirfenidone Pirfact 267mg Tablets:


Q: How should Pirfenidone Pirfact 267mg Tablets be taken?

A: Pirfenidone Pirfact 267mg Tablets are intended for oral administration and should be taken exactly as prescribed by your healthcare provider, usually three times daily with food.

Q: What is the main benefit of using Pirfenidone Pirfact for IPF?

A: Pirfact contains Pirfenidone, an antifibrotic agent, which helps slow disease progression in patients with idiopathic pulmonary fibrosis, potentially preserving lung function.

Q: When should I avoid taking Pirfenidone Pirfact 267mg Tablets?

A: Avoid using Pirfact if you have severe liver or kidney impairment, or if your doctor advises against its use due to potential health risks. Always consult your physician before starting therapy.

Q: Where has Pirfenidone Pirfact 267mg been approved for use?

A: Pirfact 267mg is globally approved in several countries, including Canada, the EU, UK, USA, and Australia, reflecting its established safety and efficacy profile.

Q: What precautions are necessary when using Pirfenidone Pirfact?

A: This medication should be used with caution in patients who have liver or kidney problems. Regular monitoring and dose adjustments by a healthcare provider may be necessary.

Q: How should Pirfenidone Pirfact 267mg Tablets be stored?

A: Store the tablets in a cool, dry place below 25C, protected from light. Follow the storage instructions on the packaging to maintain their effectiveness.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Medicines Category

Bonmax PTH 750mcg Solution Injection

Bonmax PTH 750mcg Solution Injection

Minimum Order Quantity : 100 Boxes

Application : Other, To Treat Osteoporosis

Indication : Osteoporosis Treatment

Dosage Form : Solution Injection

Physical Color/Texture : Other , Clear, Colorless Solution

Salt Composition : Teriparatide 750mcg

Sorafenet Sorafenib Tosylate Tablets

Sorafenet Sorafenib Tosylate Tablets

Minimum Order Quantity : 100 Boxes

Application : Other, Anticancer therapy

Indication : Treatment of advanced renal cell carcinoma, unresectable hepatocellular carcinoma, and differentiated thyroid carcinoma

Dosage Form : Tablet

Physical Color/Texture : Other , White to offwhite tablet

Salt Composition : Sorafenib Tosylate

Dasatinib Sprycel 50mg Tablet

Dasatinib Sprycel 50mg Tablet

Minimum Order Quantity : 100 Boxes

Application : Other, Pharmaceutical use for cancer therapy

Indication : Treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL)

Dosage Form : Tablet

Physical Color/Texture : Other , White to offwhite filmcoated tablet

Salt Composition : Dasatinib 50mg

Acuwel 20 Isotretinoin SoftGel Capsules 20 mg

Acuwel 20 Isotretinoin SoftGel Capsules 20 mg

Minimum Order Quantity : 100 Packs

Application : Other, Oral use, dermatological therapy

Indication : Severe acne (nodular, cystic); resistant acne

Dosage Form : SoftGel Capsules

Physical Color/Texture : Other , Soft gel capsules

Salt Composition : Isotretinoin 20 mg



Back to top